Yolk sac tumor of the testicle

Yolk sac tumor of the testicle, also known as Dertholder's tumor, refers to a group of malignant neoplasms arising from the yolk sac cells, which are part of the gonads. These tumors represent a relatively small percentage of all testicular tumors and typically occur in young and middle-aged men. The clinical picture can vary from asymptomatic to severe symptoms such as testicular enlargement, pain, and discomfort. The main feature of yolk sac tumors is their heterogeneity, which necessitates comprehensive diagnosis and treatment. The prognosis for patients depends on the stage of the disease at diagnosis and the effectiveness of the treatment, which emphasizes the importance of early recognition and intervention.

History of the disease and interesting historical facts

Yolk sac tumors were first described in the 1930s, when the medical community began actively studying testicular neoplasms and their differences. The first clinical observations allowed us to identify yolk sac tumors as an independent disease. Historically, most early studies were based on analyses and biopsies, which allowed us to better understand the morphological features of these tumors. In 1970, a classification of testicular tumors was proposed that included the definition of yolk sac tumors. This contributed to the further development of diagnostics and therapy, as well as a deeper understanding of the etiology of this disease.

Epidemiology

Yolk sac tumors have a low but stable incidence. Globally, their incidence ranges from 1 to 2% of all testicular cancer cases. Approximately 2-3 cases per 100,000 men per year make it necessary to focus on this tumor. According to population studies, yolk sac tumors are most often detected in men aged 15 to 35 years, which places this category in the high-risk group. It is also noted that in some countries, such as the United States and Scandinavian countries, the incidence is slightly higher, which may be due to both genetic and environmental factors.

Genetic predisposition to this disease

Studies show that genetic predisposition plays an important role in the development of yolk sac tumors. Mutations in genes such as KIT, TP53, and some others may contribute to the development of this disease. For example, mutations in the KIT gene, which is associated with the regulation of cell growth and differentiation, are often found in patients with malignant yolk sac tumors. Genetic polymorphisms in such oncogenes may also be risk markers. In addition, an association has been observed between testicular lineage abnormalities and the presence of yolk sac tumors, highlighting the need for genetic counseling for families with cases of such neoplasms.

Risk factors for the development of this disease

Risk factors for yolk sac tumors include both physical and chemical exposures. Physical factors include:

• Part of cryptorchidism, a condition in which the testicle has not fully descended into the scrotum.
• Changes in the structure of sex chromosomes.
• Presence of trauma or surgery on the testicles.

Chemical risk factors include:

• Exposure to certain chemicals, such as pesticides.
• Contact with heavy metals and other toxic substances that occur during work.

Other possible related factors:

• Family history of testicular cancer.
• Previously transferred tumors.
• Age - most often found in young men.

Diagnosis of this disease

Diagnosis of yolk sac tumor is multifaceted and involves several key steps. The main symptoms to look out for include testicular enlargement, pain, and the presence of lumps. Laboratory tests typically begin with testing for tumor markers such as alpha-fetoprotein (AFP) and beta-hCG. Radiological tests such as ultrasound or CT scans help visualize the size and location of the tumor.

Other diagnostic methods include:

• Magnetic resonance imaging (MRI) for more in-depth analysis.
• Biopsy if necessary to confirm the diagnosis.

Differential diagnosis must be carried out with other testicular tumors and benign formations, which requires careful analysis of the clinical picture and research results.

Treatment

Treatment of yolk sac tumors includes several approaches, which depend on the stage of the disease and the general condition of the patient. General treatment consists of surgical intervention, usually orchiectomy, which involves removal of the affected testicle. Pharmacological therapy includes chemotherapy using drugs such as platinum-containing compounds, as well as other cytostatics. In some cases, radiotherapy may be necessary, especially in metastatic cases.

Additional treatments vary depending on individual circumstances, but it is important to consider potential side effects and post-therapy monitoring of the patient's condition.

List of medications used to treat this disease

The following drugs are used to treat yolk sac tumors:

• Cisplatin
• Etamsuteril
• Vinblastine
• Bleomycin

These drugs are often used in treatment regimens aimed at killing tumor cells and preventing disease recurrence.

Disease monitoring

Monitoring of patients with yolk sac tumor includes regular follow-up examinations and Tumor marker tests. It is important to have satisfactory results for at least five years after treatment, which is often an indicator of successful therapy. The prognosis varies depending on the historical stage, the presence of metastases, and compliance with the recommendations of the treating physician. Possible complications may include recurrence of the disease, damage to nearby organs, and deterioration of sexual function.

Age-related features of the disease

Yolk sac tumor has its own characteristics of the course in different age groups. In young men, especially between the ages of 15 and 35, the disease is characterized by a more aggressive course and a high probability of metastasis. At an older age, although rare, more slowly progressing forms can occur. It is also important to note that elderly patients have more pronounced concomitant diseases, which can significantly complicate treatment and monitoring of the condition.

Questions and Answers

• What are the main symptoms of yolk sac tumor? The main symptoms include enlargement of the testicle, pain, lumps and sometimes general malaise.
• How is yolk sac tumor different from other testicular tumors? Yolk sac tumor has specific markers such as alpha-fetoprotein (AFP) and differs histologically from other tumor types.
• Can yolk sac tumor be prevented? There are currently no known methods of prevention, but it is important to monitor for symptoms and have regular medical checkups, especially if risk factors are present.
• What are the survival rates for yolk sac tumor? The prognosis depends on the stage of the disease, but in most cases, with timely diagnosis and treatment, the five-year survival rate is about 90%.
• Is chemotherapy necessary after surgery? Yes, in many cases chemotherapy is recommended to prevent recurrence of the disease, especially if there are metastases or a high risk of their development.